Back to Search
YAGO NIETO, M.D.
M.D.
Internal Medicine Physician
NPI: 1245243948IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
M3671(TX)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
M3671(TX)
CMS Specialties
PrimaryHEMATOPOIETIC CELL TRANSPLANTATION AND CELLULAR THERAPY
Additional
Education
OTHER
Class of 1990
Research & Publications (20)
High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?
PMID 19532017·Curr Opin Oncol·2009
6-review
Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.
PMID 17950919·Biol Blood Marrow Transplant·2007
3-trial
Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer.
PMID 17906204·J Clin Oncol·2007
8-other
Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy.
PMID 17609662·Br J Cancer·2007
8-other
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer.
PMID 19526361·Cancer Chemother Pharmacol·2010
3-trial
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
PMID 19450756·Biol Blood Marrow Transplant·2009
8-other
Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation.
PMID 19450763·Biol Blood Marrow Transplant·2009
6-review
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
PMID 19144658·Haematologica·2009
8-other
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
PMID 19041063·Biol Blood Marrow Transplant·2008
3-trial
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.
PMID 18215777·Biol Blood Marrow Transplant·2008
6-review
Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma.
PMID 18536525·Oncology·2008
3-trial
Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab.
PMID 17329225·Clin Transl Oncol·2007
8-other
Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule.
PMID 17652061·Clin Transl Oncol·2007
5-case
Functional characterization of the gene cluster from Pseudomonas syringae pv. phaseolicola NPS3121 involved in synthesis of phaseolotoxin.
PMID 17237165·J Bacteriol·2007
8-other
Prognostic value of nodal ratios in node-positive breast cancer.
PMID 16782931·J Clin Oncol·2006
1-meta
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.
PMID 16443519·Biol Blood Marrow Transplant·2006
3-trial
Idiopathic hyperammonemia following high-dose chemotherapy.
PMID 16547487·Bone Marrow Transplant·2006
5-case
Docetaxel administered during pregnancy for inflammatory breast carcinoma.
PMID 16595038·Clin Breast Cancer·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1245243948
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile